LATEST NEWS

Phase I/II Study Of Radiation Enhancing Hafnium Oxide Nanoparticles NBTXR3 Activated by SBRT in HCC and Liver Metastases Patients

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.